Pharmsville Co., Ltd. Logo

Pharmsville Co., Ltd.

Develops and sells health supplements, specializing in microbiome-based probiotics.

318010 | KO

Overview

Corporate Details

ISIN(s):
KR7318010006
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙8로3길 37 -, 강서구

Description

Pharmsville Co., Ltd. is a bio-healthcare company that develops, produces, and sells health functional foods and natural supplements. Founded in 2000, the company focuses on extending human healthspan through the research and development of novel ingredients, with a specialization in microbiome-based probiotics. Its product portfolio is marketed to both domestic and international consumers under brands such as 'Appletree Dr.'. The company supports its innovation through dedicated research facilities, including the Pharmsville Bio Lab, aiming to create health products that are as natural as possible for the human body.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-04-29 00:00
소속부변경
Korean 3.6 KB
2022-03-25 00:00
정기주주총회결과
Korean 26.7 KB
2022-03-18 00:00
[첨부추가]사업보고서 (2021.12)
Korean 1.4 MB
2022-03-17 00:00
감사보고서제출
Korean 25.0 KB
2022-03-10 00:00
주주총회소집공고
Korean 127.0 KB
2022-02-11 00:00
주주총회소집결의
Korean 15.9 KB
2022-02-11 00:00
현금ㆍ현물배당결정
Korean 8.9 KB
2022-02-11 00:00
주주총회집중일개최사유신고
Korean 4.8 KB
2022-02-04 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 12.4 KB
2021-12-15 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2021-11-12 00:00
분기보고서 (2021.09)
Korean 1.2 MB
2021-09-13 00:00
조회공시요구(현저한시황변동)에대한답변(중요정보없음)
Korean 5.3 KB
2021-09-10 00:00
조회공시요구(현저한시황변동)
Korean 3.5 KB
2021-08-13 00:00
반기보고서 (2021.06)
Korean 1.3 MB
2021-05-17 00:00
분기보고서 (2021.03)
Korean 1.3 MB

Automate Your Workflow. Get a real-time feed of all Pharmsville Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharmsville Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharmsville Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.